Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial
Author(s):
Wermke, M.; Eckoldt, J.; Gotze, K.S.; Klein, S.A.; Bug, G.; Wreede, L.C. de (0000-0002-7667-9369); Kramer, M.; Stolzel, F.; Bonin, M. von; Schetelig, J.; Laniado, M.; Plodeck, V.; Hofmann, W.K.; Ehninger, G.; Bornhauser, M.; Wolf, D.; Theurl, I.; Platzbecker, U.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-05-31
Language
English
Is part of
Lancet Haematology (2018), Vol. 5, no. 5, p. E201-E210
